文献
J-GLOBAL ID:201702282651119071
整理番号:17A1286394
BFM-90処方におけるPEG-アスパラギナーゼは新たに診断されたリンパ芽球性リンパ腫の成人における転帰を改善する【JST・京大機械翻訳】
PEG-asparaginase in BFM-90 regimen improves outcomes in adults with newly diagnosed lymphoblastic lymphoma
著者 (16件):
Wen Zheng
(KEY LABORATORY OF CARCINOGENESIS AND TRANSLATIONAL RESEARCH(MINISTRY OF EDUCATION/BEIJING), DEPARTMENT OF LYMPHOMA, PEKING UNIVERSITY CANCER HOSPITAL & INSTITUTE, BEIJING 100142, CHINA)
,
Hanyun Ren
(DEPARTMENT OF HEMATOLOGY, PEKING UNIVERSITY FIRST HOSPITAL, BEIJING 100034, CHINA)
,
Xiaoyan Ke
(DEPARTMENT OF HEMATOLOGY, PEKING UNIVERSITY THIRD HOSPITAL, BEIJING 100191, CHINA)
,
Mei Xue
(DEPARTMENT OF HEMATOLOGY, AIR FORCE GENERAL HOSPITAL OF CHINESE PEOPLE’S LIBERATION ARMY, BEIJING 100142, CHINA)
,
Yongqing Zhang
(DEPARTMENT OF HEMATOLOGY, THE 309TH HOSPITAL OF CHINESE PEOPLE’S LIBERATION ARMY, BEIJING 100091, CHINA)
,
Yan Xie
(KEY LABORATORY OF CARCINOGENESIS AND TRANSLATIONAL RESEARCH(MINISTRY OF EDUCATION/BEIJING), DEPARTMENT OF LYMPHOMA, PEKING UNIVERSITY CANCER HOSPITAL & INSTITUTE, BEIJING 100142, CHINA)
,
Ningjing Lin
(KEY LABORATORY OF CARCINOGENESIS AND TRANSLATIONAL RESEARCH(MINISTRY OF EDUCATION/BEIJING), DEPARTMENT OF LYMPHOMA, PEKING UNIVERSITY CANCER HOSPITAL & INSTITUTE, BEIJING 100142, CHINA)
,
Meifeng Tu
(KEY LABORATORY OF CARCINOGENESIS AND TRANSLATIONAL RESEARCH(MINISTRY OF EDUCATION/BEIJING), DEPARTMENT OF LYMPHOMA, PEKING UNIVERSITY CANCER HOSPITAL & INSTITUTE, BEIJING 100142, CHINA)
,
Weiping Liu
(KEY LABORATORY OF CARCINOGENESIS AND TRANSLATIONAL RESEARCH(MINISTRY OF EDUCATION/BEIJING), DEPARTMENT OF LYMPHOMA, PEKING UNIVERSITY CANCER HOSPITAL & INSTITUTE, BEIJING 100142, CHINA)
,
Lingyan Ping
(KEY LABORATORY OF CARCINOGENESIS AND TRANSLATIONAL RESEARCH(MINISTRY OF EDUCATION/BEIJING), DEPARTMENT OF LYMPHOMA, PEKING UNIVERSITY CANCER HOSPITAL & INSTITUTE, BEIJING 100142, CHINA)
,
Zhitao Ying
(KEY LABORATORY OF CARCINOGENESIS AND TRANSLATIONAL RESEARCH(MINISTRY OF EDUCATION/BEIJING), DEPARTMENT OF LYMPHOMA, PEKING UNIVERSITY CANCER HOSPITAL & INSTITUTE, BEIJING 100142, CHINA)
,
Chen Zhang
(KEY LABORATORY OF CARCINOGENESIS AND TRANSLATIONAL RESEARCH(MINISTRY OF EDUCATION/BEIJING), DEPARTMENT OF LYMPHOMA, PEKING UNIVERSITY CANCER HOSPITAL & INSTITUTE, BEIJING 100142, CHINA)
,
Lijuan Deng
(KEY LABORATORY OF CARCINOGENESIS AND TRANSLATIONAL RESEARCH(MINISTRY OF EDUCATION/BEIJING), DEPARTMENT OF LYMPHOMA, PEKING UNIVERSITY CANCER HOSPITAL & INSTITUTE, BEIJING 100142, CHINA)
,
Xiaopei Wang
(KEY LABORATORY OF CARCINOGENESIS AND TRANSLATIONAL RESEARCH(MINISTRY OF EDUCATION/BEIJING), DEPARTMENT OF LYMPHOMA, PEKING UNIVERSITY CANCER HOSPITAL & INSTITUTE, BEIJING 100142, CHINA)
,
Yuqin Song
(KEY LABORATORY OF CARCINOGENESIS AND TRANSLATIONAL RESEARCH(MINISTRY OF EDUCATION/BEIJING), DEPARTMENT OF LYMPHOMA, PEKING UNIVERSITY CANCER HOSPITAL & INSTITUTE, BEIJING 100142, CHINA)
,
Jun Zhu
(KEY LABORATORY OF CARCINOGENESIS AND TRANSLATIONAL RESEARCH(MINISTRY OF EDUCATION/BEIJING), DEPARTMENT OF LYMPHOMA, PEKING UNIVERSITY CANCER HOSPITAL & INSTITUTE, BEIJING 100142, CHINA)
資料名:
Zhongguo Aizheng Yanjiu(Yingwenban)
(Zhongguo Aizheng Yanjiu(Yingwenban))
巻:
29
号:
1
ページ:
66-74
発行年:
2017年
JST資料番号:
C2634A
ISSN:
1000-9604
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
中国 (CHN)
言語:
英語 (EN)